Moderna Stock Is at a Crossroads. Is the Path Ahead One of Profit or Pain for MRNA?

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Could Covid-19 vaccines secretly boost cancer survival? Scientists say mRNA shows unexpected potential to aid cancer treatment

New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune ...
GlobalData on MSN

Funds dry up for mRNA vaccines amid US political storm

This culminated in a $500m funding cut to mRNA vaccine research funding, impacting around 22 projects being run at the Biomedical Advanced Research and Development Authority (BARDA). Grants withdrawn ...
STAT

Moderna co-founder Noubar Afeyan issues warning: Assault on science ‘isn’t going to stop at mRNA’

Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...
ABC7

Technology used to make COVID vaccines tested to treat HIV, cancer, more

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Pharmaceutical Technology

Venture financing for mRNA-based vaccines declines 82% in 2025 YTD

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m in the 2025's year to date (YTD), according to GlobalData’s Pharma ...